Scholarlink

<p>In 2019, the U.S. Advisory Committee on Immunization Practices recommended shared clinical decision-making (SCDM) for HPV vaccination among unvaccinated adults aged 27–45 years (i.e., mid-adult). However, the implementation of this recommendation is challenging. This study assessed a decision tool, HPV Decide, designed to facilitate SCDM for mid-adult HPV vaccination. We used exploratory sequential mixed methods to gather stakeholder and provider perspectives on a beta version of HPV Decide. Qualitative feedback from providers and stakeholders (<i>N</i> = 24) was collected through semi-structured interviews. Quantitative data from health care providers (<i>N</i> = 600) on usability in clinical practice was collected via online surveys. Interviewees provided feedback on the preferred delivery method and timing, the need for support and training, and key barriers and facilitators to SCDM. Quantitative data showed that 68.3% of providers were likely to use the tool, 67% believed it could be easily integrated into practice, and 54% thought patients would be interested in using it. Findings suggest that a web-based decision tool to facilitate SCDM for mid-adult HPV vaccination is both acceptable and feasible for integration into clinical practice. Providers expressed strong preferences for clinic-based access and electronic delivery. Clinicians supported the integration of a web-based decision tools into clinical practice to enhance shared decision-making.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinician Perspectives on the Implementation of a Web-Based Tool to Support Shared Decision-Making for Mid-Adult HPV Vaccination

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月9日

查看全文
  • Christopher W. Wheldon,
  • Sarah A. Alkhatib,
  • Jessica Grace,
  • Idara N. Akpan,
  • Ellen M. Daley,
  • Gregory D. Zimet,
  • Justin Luningham,
  • Jonathan Engler,
  • Erika L. Thompson

摘要

In 2019, the U.S. Advisory Committee on Immunization Practices recommended shared clinical decision-making (SCDM) for HPV vaccination among unvaccinated adults aged 27–45 years (i.e., mid-adult). However, the implementation of this recommendation is challenging. This study assessed a decision tool, HPV Decide, designed to facilitate SCDM for mid-adult HPV vaccination. We used exploratory sequential mixed methods to gather stakeholder and provider perspectives on a beta version of HPV Decide. Qualitative feedback from providers and stakeholders (N = 24) was collected through semi-structured interviews. Quantitative data from health care providers (N = 600) on usability in clinical practice was collected via online surveys. Interviewees provided feedback on the preferred delivery method and timing, the need for support and training, and key barriers and facilitators to SCDM. Quantitative data showed that 68.3% of providers were likely to use the tool, 67% believed it could be easily integrated into practice, and 54% thought patients would be interested in using it. Findings suggest that a web-based decision tool to facilitate SCDM for mid-adult HPV vaccination is both acceptable and feasible for integration into clinical practice. Providers expressed strong preferences for clinic-based access and electronic delivery. Clinicians supported the integration of a web-based decision tools into clinical practice to enhance shared decision-making.